Using mindfulness to help adolescents with Type 1 diabetes manage stress and anxiety
Mindfulness-Based Stress Reduction in Adolescents with Type 1 Diabetes
This study is testing a special program to help teenagers with Type 1 diabetes learn how to manage their anxiety and stress better, so they can feel happier and take better care of their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10758782 on NIH RePORTER |
What this research studies
This research focuses on adolescents with Type 1 diabetes, a condition that can lead to serious health complications. It aims to adapt a mindfulness-based stress reduction program to help these young individuals manage anxiety, which is common among them and can negatively impact their diabetes management. By participating in this program, adolescents will learn techniques to reduce stress and improve their overall quality of life and self-management of their condition. The approach is systematic and tailored to meet the unique needs of adolescents living with diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 18 years who have been diagnosed with Type 1 diabetes.
Not a fit: Patients who do not have Type 1 diabetes or are outside the age range of 12 to 18 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the mental health and diabetes management of adolescents, leading to better health outcomes.
How similar studies have performed: Previous research has shown that mindfulness-based interventions can be effective in reducing anxiety and improving quality of life in various populations, suggesting potential success in this novel application.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Rechenberg, Kaitlyn — University of South Florida
- Study coordinator: Rechenberg, Kaitlyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.